[Therapy and prognosis of hypernephroid kidney carcinoma].
D000230:Adenocarcinoma / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000528:radiation effects; D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004583:Electrons; D006801:Humans; D007680:Kidney Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D009392:Nephrectomy; D011182:Postoperative Care; D011300:Preoperative Care; D011379:Prognosis; D011830:Radiation Effects; D011832:Radiation Injuries; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000379:methods; D009626:Terminology as Topic
D000970:Antineoplastic Agents; D003037:Cobalt Radioisotopes; D003520:Cyclophosphamide
Therapie und Prognose des hypernephroiden Nierenkarzinoms